Arvee Labs FY26 Net Profit Rises to ₹252.63 Lakh
Arvee Laboratories (India) Limited reported a net profit of ₹252.63 lakh for FY26, up from ₹214.74 lakh in FY25. Quarterly profit for Q4 stood at ₹52.02 lakh on revenue of ₹1,080.41 lakh. Total assets increased to ₹4,325.71 lakh as of March 31, 2026.
*this image is generated using AI for illustrative purposes only.
Arvee Laboratories (India) Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the financial statements during a meeting held on May 19, 2026. The company reported a net profit of ₹252.63 lakh for the fiscal year 2025-26, marking an increase from ₹214.74 lakh in the previous year.
For the quarter ended March 31, 2026, the company posted a net profit of ₹52.02 lakh. Revenue from operations for the quarter was ₹1,080.41 lakh, while total income stood at ₹1,095.04 lakh. The total expenses for the quarter were reported at ₹1,009.67 lakh.
Financial Performance for FY26
The annual revenue from operations for the year ended March 31, 2026, was recorded at ₹3,151.41 lakh, a decrease from ₹3,848.72 lakh in the prior year. Total income for the year amounted to ₹3,219.52 lakh. The company managed its total expenses effectively, bringing them down to ₹2,976.47 lakh from ₹3,627.36 lakh in the previous fiscal year.
| Particulars | Year Ended 31/03/2026 (₹ in Lakhs) | Year Ended 31/03/2025 (₹ in Lakhs) |
|---|---|---|
| Revenue from operations | 3,151.41 | 3,848.72 |
| Total Income | 3,219.52 | 3,914.45 |
| Total Expenses | 2,976.47 | 3,627.36 |
| Profit for the period | 252.63 | 214.74 |
| Earnings per share (Basic) | 2.29 | 1.95 |
Segment Reporting
The company's operations are primarily divided into Textile and Non-textile segments. For the year ended March 31, 2026, the Non-textile segment contributed significantly to the revenue, reporting ₹2,757.89 lakh, while the Textile segment reported ₹461.63 lakh. The total segment revenue for the year was ₹3,219.52 lakh.
Balance Sheet Highlights
The total assets of the company as of March 31, 2026, stood at ₹4,325.71 lakh, up from ₹3,815.83 lakh in the previous year. The equity and liabilities mirrored this growth, with total equity and liabilities recorded at ₹4,325.71 lakh. The company's paid-up equity share capital remained constant at ₹1,102.00 lakh.
The auditors, M/s. Nirav Patel & Associates, issued an unmodified opinion on the standalone financial results. The board also approved the Statement of Related Party Transactions for the half-year ended March 31, 2026.
Historical Stock Returns for Arvee Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.44% | -2.36% | -2.87% | -2.24% | -2.94% | +23.15% |
Given the ~18% decline in annual revenue from operations despite improved profitability, what strategic cost-cutting measures is Arvee Laboratories planning to sustain or improve margins in FY27?
With the Non-textile segment contributing nearly 85% of total segment revenue, is the company considering divesting or scaling down its Textile segment to focus resources on higher-performing operations?
How does Arvee Laboratories plan to deploy the growth in total assets from ₹3,815.83 lakh to ₹4,325.71 lakh to drive revenue recovery in the upcoming fiscal year?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
